METRONIDazole Injection, USP 500 mg (5 mg/mL), 100 mL Bag, Rx only, Hospira, Inc Supply Disruption — Hospira Inc. (Moderate Risk —
METRONIDazole Injection, USP 500 mg (5 mg/mL), 100 mL Bag, Rx only, Hospira, Inc Supply Disruption — Hospira Inc. (Moderate Risk — is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: METRONIDazole Injection, USP 500 mg (5 mg/mL), 100 mL Bag, Rx only, Hospira, Inc; Manufacturer: Hospi
| Drug name | METRONIDazole Injection, USP 500 mg (5 mg/mL), 100 mL Bag, Rx only, Hospira, Inc |
|---|---|
| Manufacturer | Hospira Inc. |
| Recall/Disruption reason | Lack of Assurance of Sterility: There is the potential for the solution to leak from the administrative port to the fill |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-206-2013 |
| Initiation date | 20130215 |
| Quantity affected | 567,624 bags |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →